Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 6/24/2026 | Outperform → Mkt Perform | Raymond James | |
| 4/16/2026 | $74.00 | Equal-Weight | Morgan Stanley |
| 1/14/2026 | $65.00 | Buy → Hold | Truist |
| 12/12/2025 | $62.00 | Neutral | Citigroup |
| 8/13/2025 | $65.00 | Neutral → Buy | BofA Securities |
| 6/24/2025 | $55.00 | Buy | Stifel |
| 4/16/2025 | $51.00 | Underweight | Morgan Stanley |
| 1/21/2025 | $64.00 | Buy | Citigroup |
NEW YORK, July 20, 2026 /PRNewswire/ -- S&P Dow Jones Indices will make the following changes to the S&P MidCap 400, S&P SmallCap 600: S&P SmallCap 600 constituent Krystal Biotech Inc. (NASD: KRYS) will replace Taylor Morrison Home Corp. (NYSE:TMHC) in the S&P MidCap 400, and Tutor Perini Corp. (NYSE:TPC) will replace Krystal Biotech in the S&P SmallCap 600 effective prior to the opening of trading on Friday, July 24. S&P 500 & 100 constituent Berkshire Hathaway Inc. (NYSE:BRK) is acquiring Taylor Morrison Home in a deal expected to close on or about that date, pending final closing conditions. V2X Inc. (NYSE: VVX) will replace Avanos Medical Inc. (NYSE:AVNS) in the S&P SmallCap 600 effect
RESTON, Va., July 14, 2026 /PRNewswire/ -- V2X, Inc., (NYSE:VVX), a leading provider of global mission solutions, will report second quarter 2026 financial results on Monday, August 3, 2026, after market close. Senior management will conduct a conference call at 4:30 p.m. ET that same day. U.S.-based participants may dial in to the conference call at 877-300-8521, while international participants may dial 412-317-6026. A live webcast of the conference call as well as an accompanying slide presentation will be available at https://app.webinar.net/9LeOmbNmDjb and on the Investors section of the V2X website at https://gov2x.com/.A
RESTON, Va., June 5, 2026 /PRNewswire/ -- V2X, Inc., (NYSE:VVX), a leading provider of global mission solutions, announced that company management will engage in a fireside chat and question-and-answer session at the 16th Annual Wells Fargo Industrials & Materials Conference on Tuesday, June 9, at 10:30 a.m. Eastern time. A live webcast of the event will be available at https://event.summitcast.com/view/QCgpAyoWWxBHCfAopjr3F6/TcG7C8PRBuJk7irUzGvWnn and be available for replay for 90 days afterward.About V2XV2X builds innovative solutions that integrate physical and digital environments by aligning people, actions, and technolog
4 - V2X, Inc. (0001601548) (Issuer)
4 - V2X, Inc. (0001601548) (Issuer)
4 - V2X, Inc. (0001601548) (Issuer)
Raymond James downgraded V2X from Outperform to Mkt Perform
Morgan Stanley resumed coverage of V2X with a rating of Equal-Weight and set a new price target of $74.00
Truist downgraded V2X from Buy to Hold and set a new price target of $65.00
4 - V2X, Inc. (0001601548) (Issuer)
4 - V2X, Inc. (0001601548) (Issuer)
4 - V2X, Inc. (0001601548) (Issuer)
SCHEDULE 13G - V2X, Inc. (0001601548) (Subject)
8-K - V2X, Inc. (0001601548) (Filer)
SCHEDULE 13G - V2X, Inc. (0001601548) (Subject)
RESTON, Va., July 14, 2026 /PRNewswire/ -- V2X, Inc., (NYSE:VVX), a leading provider of global mission solutions, will report second quarter 2026 financial results on Monday, August 3, 2026, after market close. Senior management will conduct a conference call at 4:30 p.m. ET that same day. U.S.-based participants may dial in to the conference call at 877-300-8521, while international participants may dial 412-317-6026. A live webcast of the conference call as well as an accompanying slide presentation will be available at https://app.webinar.net/9LeOmbNmDjb and on the Investors section of the V2X website at https://gov2x.com/.A
First Quarter Financial HighlightsRevenue of $1.25 billion, up 23% year-over-yearNet income of $18.9 million; Adjusted net income1 of $48.1 million, up 53% year-over-yearAdjusted EBITDA1 of $85.6 million; Adjusted EBITDA1 margin of 6.8%Diluted EPS of $0.60; Adjusted diluted EPS1 of $1.53, up 55% year-over-yearRecord backlog1 of $13.8 billion, driven by 3.2x book-to-bill1 in the quarterIncreasing 2026 Guidance Increasing full-year 2026 guidance with 9% revenue and adjusted EBITDA1 growth at the midpointRESTON, Va., May 4, 2026 /PRNewswire/ -- V2X, Inc. (NYSE:VVX) today announced first quarter 2026 financial results, and increased guidance for full-year 2026.
RESTON, Va., April 20, 2026 /PRNewswire/ -- V2X, Inc., (NYSE:VVX), a leading provider of global mission solutions, will report first quarter 2026 financial results on Monday, May 4, 2026, after market close. Senior management will conduct a conference call at 4:30 p.m. ET that same day. U.S.-based participants may dial in to the conference call at 877-300-8521, while international participants may dial 412-317-6026. A live webcast of the conference call as well as an accompanying slide presentation will be available at https://app.webinar.net/Q291YZzYJpN and on the Investors sec
NEW YORK, July 20, 2026 /PRNewswire/ -- S&P Dow Jones Indices will make the following changes to the S&P MidCap 400, S&P SmallCap 600: S&P SmallCap 600 constituent Krystal Biotech Inc. (NASD: KRYS) will replace Taylor Morrison Home Corp. (NYSE:TMHC) in the S&P MidCap 400, and Tutor Perini Corp. (NYSE:TPC) will replace Krystal Biotech in the S&P SmallCap 600 effective prior to the opening of trading on Friday, July 24. S&P 500 & 100 constituent Berkshire Hathaway Inc. (NYSE:BRK) is acquiring Taylor Morrison Home in a deal expected to close on or about that date, pending final closing conditions. V2X Inc. (NYSE: VVX) will replace Avanos Medical Inc. (NYSE:AVNS) in the S&P SmallCap 600 effect
RESTON, Va., April 2, 2026 /PRNewswire/ -- V2X, Inc. (NYSE:VVX) today announced the appointment of Mike Uster as Chief Information Officer, effective immediately. In this role, Uster will lead the company's global information technology strategy, enterprise systems, and digital transformation initiatives, with a focus on strengthening cybersecurity, advancing AI-enabled capabilities, and enabling secure, resilient technology platforms that support V2X's mission-critical operations. He will report directly to Jeremy C. Wensinger, President and Chief Executive Officer at V2X. Uste
RESTON, Va., Oct. 13, 2025 /PRNewswire/ -- V2X, Inc. (NYSE:VVX), today announced the appointment of Jeff Cheatham as Vice President of Contracts and Subcontracts. In this role, Cheatham will oversee all contract strategy, negotiation, and administration activities across the enterprise, ensuring excellence in execution, compliance, and customer engagement in support of V2X's global operations. He will report to V2X General Counsel, Jeremy Nance. Cheatham brings more than 25 years of experience in federal contracting, procurement, and business leadership. He joins V2X from Pera
SC 13D/A - V2X, Inc. (0001601548) (Subject)
SC 13G/A - V2X, Inc. (0001601548) (Subject)
SC 13G/A - V2X, Inc. (0001601548) (Subject)